Viewing StudyNCT05143840


Ignite Creation Date: 2025-12-18 @ 9:19 AM
Ignite Modification Date: 2025-12-23 @ 6:43 PM
Study NCT ID: NCT05143840
Status: None
Last Update Posted: 2025-04-08 00:00:00
First Post: 2021-11-16 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Sponsor: None
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-04-22
Start Date Type: ACTUAL
Primary Completion Date: 2032-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2032-02
Completion Date Type: ESTIMATED
First Submit Date: 2021-11-16 00:00:00
First Submit QC Date: None
Study First Post Date: 2021-12-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-04 00:00:00
Last Update Post Date: 2025-04-08 00:00:00
Last Update Post Date Type: ACTUAL